Cabaletta Bio Inc (CABA) stock saw a decline, ending the day at $2.36 which represents a decrease of $-0.02 or -0.84% from the prior close of $2.38. The stock opened at $2.4 and touched a low of $2.25 ...
Fintel reports that on December 19, 2024, Wells Fargo downgraded their outlook for Cabaletta Bio (NasdaqGS:CABA) from ...
Evercore ISI lowered shares of Cabaletta Bio (NASDAQ:CABA – Free Report) from an outperform rating to an inline rating in a research note published on Friday morning, MarketBeat.com reports. They ...
PHILADELPHIA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...
The Prospects Live crew breaks down the tools of their 2nd-ranked player in the Philadelphia Phillies farm system, infield ...